ストックスクリーナーアプリを入手
2.70
0.00%
0.00
前日終値:
$2.70
開ける：
$2.7
24時間の取引高:
180.04K
Relative Volume:
3.54
時価総額：
$80.16M
収益：
$6.21M
当期純損益:
$-19.92M
株価収益率:
-2.5714
EPS:
-1.05
ネットキャッシュフロー:
$-16.76M
1週間 パフォーマンス:
-1.46%
1か月 パフォーマンス:
-19.64%
6か月 パフォーマンス:
-1.82%
1年 パフォーマンス:
+13.92%
1日の値動き範囲:
$2.57
$2.708
1週間の範囲:
$2.55
$2.81
52週間の値動き範囲:
$1.81
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
NSPR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.70 | 80.16M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2016-01-07 | 開始されました | Rodman & Renshaw | Buy |
| 2015-03-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 開始されました | Oppenheimer | Outperform |
InspireMD Inc. (NSPR) 最新ニュース
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates - MSN
InspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... By GuruFocus - Investing.com Canada
InspireMD Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
InspireMD’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
InspireMD earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings call transcript: InspireMD Q4 2024 beats revenue forecast, stock rises - Investing.com India
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
InspireMD reports Q4 EPS (19c) vs (16c) last year - TipRanks
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
InspireMD Achieves Record $1.95M Revenue as FDA Approval Nears - StockTitan
InspireMD, Inc. SEC 10-K Report - TradingView
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD (NYSE:NSPR) and Bluejay Diagnostics (NASDAQ:BJDX) Head to Head Survey - Defense World
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
InspireMD, Inc. to Host Earnings Call - ACCESS Newswire
InspireMD announces inducement grants under Nasdaq listing rule - MSN
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
When Will InspireMD Release Its 2024 Results? Key Date for Carotid Stent Maker Announced - StockTitan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is InspireMD's Hiring Spree a Signal for Investors? Company Awards 138K Shares to New Talent - StockTitan
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years - Yahoo Finance
NSPR stock touches 52-week high at $3.43 amid robust growth - Investing.com
InspireMD and NAMSA to begin study of carotid stent system for TCAR procedures - Yahoo
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire
InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures - Marketscreener.com
Major Clinical Trial Alert: InspireMD's Revolutionary TCAR Stent Targets $1B+ Market - StockTitan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St
Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı
InspireMD Awards Strategic Employee Stock Grants to Accelerate Growth, Adds 9 New Hires - StockTitan
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
InspireMD Inc. (NSPR) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
0.10%
大文字化:
|
ボリューム (24 時間):